triazoles has been researched along with Niemann-Pick Disease, Type C in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ballout, RA; Bukrinsky, MI; Remaley, AT; Sviridov, D | 1 |
Bernardo, A; De Nuccio, C; Ferrante, A; Minghetti, L; Pepponi, R; Popoli, P; Visentin, S | 1 |
2 other study(ies) available for triazoles and Niemann-Pick Disease, Type C
Article | Year |
---|---|
The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.
Topics: ADAM17 Protein; Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Benzylisoquinolines; Betacoronavirus; Biological Transport; Cathepsin L; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Endocytosis; Endosomes; Glycopeptides; Humans; Hydroxychloroquine; Intracellular Signaling Peptides and Proteins; Lysosomes; Membrane Lipids; Membrane Microdomains; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Oxysterols; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptors, Virus; SARS-CoV-2; Serine Endopeptidases; Triazoles; Virus Internalization | 2020 |
The stimulation of adenosine A2A receptors ameliorates the pathological phenotype of fibroblasts from Niemann-Pick type C patients.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Calcium; Case-Control Studies; Cell Line; Cholesterol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Electron Transport Complex IV; Extracellular Signal-Regulated MAP Kinases; Female; Fibroblasts; Humans; Lysosomes; Male; Membrane Potential, Mitochondrial; Mitochondria; Niemann-Pick Disease, Type C; Phenethylamines; Phenotype; Receptor, Adenosine A2A; Triazines; Triazoles | 2013 |